Dynavax Technologies | Egenkapital Og Reserver



Equity Capital And Reserves Lave om Dato
AbbVie USD 3.32B 2.71B 2024-12
Adma Biologics USD 349.02M 117.13M 2024-12
Amgen USD 6.21B 330M 2025-03
AstraZeneca USD 41.04B 168M 2025-03
Biogen USD 16.98B 262.7M 2025-03
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Dynavax Technologies USD 596.8M 84.63M 2024-12
Gilead Sciences USD 19.33B 856M 2024-12
Glaxosmithkline GBP 13.67B 337M 2024-12
Merck USD 48.34B 2.02B 2025-03
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Novartis USD 44.05B 605M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
TG Therapeutics USD 222.36M 30.21M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Dynavax Technologies Egenkapital Og Reserver - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2025.